Filter Results:
(793)
Show Results For
- All HBS Web
(1,552)
- People (1)
- News (333)
- Research (793)
- Multimedia (8)
- Faculty Publications (574)
Show Results For
- All HBS Web
(1,552)
- People (1)
- News (333)
- Research (793)
- Multimedia (8)
- Faculty Publications (574)
Sort by
- June 2008 (Revised January 2010)
- Supplement
Name Your Price: Compensation Negotiation at Whole Health Management (B)
By: Brian J. Hall, Deepak Malhotra and Nicole Bennett
Supplements the (A) case. View Details
Hall, Brian J., Deepak Malhotra, and Nicole Bennett. "Name Your Price: Compensation Negotiation at Whole Health Management (B)." Harvard Business School Supplement 908-065, June 2008. (Revised January 2010.)
- March 2015 (Revised November 2017)
- Case
Bonitas
By: Regina E. Herzlinger and Natalie Kindred
Bonitas, a South African medical scheme (i.e., health insurer), must navigate highly restrictive regulations that make it difficult for Bonitas to innovate, grow, and compete with market leader Discovery as well as providers of alternative insurance products. Bonitas... View Details
Keywords: Health Insurance; Health Care; South Africa; Medical Scheme; Public Policy; Bonitas; Bonitas Medical Fund; National Health Insurance; Health; Health Care and Treatment; Insurance; Policy; Health Industry; Health Industry; South Africa; Johannesburg; Africa
Herzlinger, Regina E., and Natalie Kindred. "Bonitas." Harvard Business School Case 315-020, March 2015. (Revised November 2017.)
- March 2021
- Case
Humana (A)
By: Regina E. Herzlinger and Ashley Ifeadike
To implement a bold new strategy, Humana needed to decide how to prioritize the pillars; where to own and where to partner; how much risk is acceptable; and how to continue to deliver strong operational performance while implementing a new strategy. Had the firm made... View Details
Keywords: Health & Wellness; Health Care Industry; Health Care Costs; Health Insurance; Health Insurance Marketplaces; Health Care and Treatment; Cost; Insurance; Strategy; Health Industry; United States
Herzlinger, Regina E., and Ashley Ifeadike. "Humana (A)." Harvard Business School Case 321-097, March 2021.
- Article
Disruptive Innovation: A New Diagnosis for Health Care's 'Financial Flu'
By: John Kenagy and C. M. Christensen
Kenagy, John, and C. M. Christensen. "Disruptive Innovation: A New Diagnosis for Health Care's 'Financial Flu'." hfm (Healthcare Financial Management) 56, no. 5 (May 2002): 62–66.
- June 2008 (Revised January 2010)
- Supplement
Name Your Price: Compensation Negotiation at Whole Health Management (C)
By: Brian J. Hall, Deepak Malhotra and Nicole Bennett
Supplements the (A) and (B) cases. View Details
Hall, Brian J., Deepak Malhotra, and Nicole Bennett. "Name Your Price: Compensation Negotiation at Whole Health Management (C)." Harvard Business School Supplement 908-066, June 2008. (Revised January 2010.)
- 2012
- Report
Better Outcomes, Lower Costs: A Conversation with Dr. Atul Gawande
By: Mark R. Kramer
In the face of increasing health care costs and uncertainty about health care quality in the United States, community-based collective impact initiatives driven by regional funders offers a new way to improve patient outcomes at the local level. Collectively,... View Details
Keywords: Community Foundations; Health Outcomes; Health Care and Treatment; Quality; Cost Management; United States
Kramer, Mark R. "Better Outcomes, Lower Costs: A Conversation with Dr. Atul Gawande." Report, FSG, 2012.
- August 14, 2020
- Comment
How Has COVID-19 Affected Health Insurance Offered by Small Businesses in the U.S.? Early Evidence from a Survey
By: Leemore S. Dafny, Yin Wei Soon, Zoë Cullen and Christopher T. Stanton
As the COVID-19 pandemic stretches toward its third quarter, loss of health insurance coverage has not figured prominently in the public debate. Data in this report demonstrate why that is, but also suggest that the apparent stability is fragile, with potentially... View Details
Keywords: Health Pandemics; Health Care and Treatment; Insurance; Small Business; Surveys; United States
Dafny, Leemore S., Yin Wei Soon, Zoë Cullen, and Christopher T. Stanton. "How Has COVID-19 Affected Health Insurance Offered by Small Businesses in the U.S.? Early Evidence from a Survey." NEJM Catalyst (August 14, 2020). (Commentary.)
- January 2019
- Teaching Note
Pricing PatientPing
Teaching Note for HBS No. 818-017. PatientPing sells a software platform that allows health care providers to receive real-time notifications (“pings”) when one of their patients is admitted to or discharged from a health-care facility. The platform facilitates... View Details
- September 2020 (Revised January 2021)
- Case
Catalys Pacific
In 2019, BT Slingsby founds Catalys Pacific, the first biotech “venture creation” fund in Tokyo. After convincing some of the biggest Japanese pharmaceutical firms to invest, BT hopes the fund can make a big splash and transform biotechnology innovation in Japan. After... View Details
Keywords: Pharmaceutical Companies; Biotech; Health Care; Entrepreneur; Innovation; International Business; Entrepreneurial Finance; Entrepreneurship; Finance; Innovation Strategy; Venture Capital; Strategy; Cross-Cultural and Cross-Border Issues; Pharmaceutical Industry; Biotechnology Industry; Tokyo
Krieger, Joshua Lev. "Catalys Pacific." Harvard Business School Case 821-035, September 2020. (Revised January 2021.)
- October 10, 2019
- Article
The Case for the Public Option Over Medicare for All
By: Regina E. Herzlinger and Richard Boxer
How can the United States better control its health care costs and quality and still achieve universal coverage? The strongest choice is not Medicare for All, which would eliminate private insurance; it’s the public option, which would allow people to choose from... View Details
Keywords: Universal Health Coverage; Public Option; Medicare; Health Care and Treatment; Insurance; Cost Management; Quality; United States
Herzlinger, Regina E., and Richard Boxer. "The Case for the Public Option Over Medicare for All." Harvard Business Review Digital Articles (October 10, 2019): 2–5.
- Article
Overturning the ACA's Medicaid Expansion Would Likely Decrease Low-Income, Reproductive-Age Women's Healthcare Spending and Utilization
By: Lucy Chen, Richard G. Frank and Haiden A. Huskamp
In late 2020, the Supreme Court began hearing a case challenging the Affordable Care Act (ACA), which led to coverage gains for many low-income, reproductive-age women. To explore potential implications of a full ACA repeal for this population, we examined gains... View Details
Keywords: Medicaid; Women's Health; Health Insurance; Health Care and Treatment; Gender; Insurance; Poverty; Health Industry; United States
Chen, Lucy, Richard G. Frank, and Haiden A. Huskamp. "Overturning the ACA's Medicaid Expansion Would Likely Decrease Low-Income, Reproductive-Age Women's Healthcare Spending and Utilization." Inquiry 57 (2020).
- September 2013 (Revised May 2014)
- Case
OdontoPrev
By: Regina E. Herzlinger, Matthew Lingenbrink, Joshua Turnbull and Ricardo Reisen De Pinho
Brazil's largest dental insurer, a successful and innovative firm, has saturated the corporate market and faces stiffer competition. It must decide whether to enter a new market in Brazil or to expand into other parts of Central and South America. View Details
Keywords: Health; Business or Company Management; Market Entry and Exit; Insurance; Health Industry; Health Industry; North and Central America; Brazil
Herzlinger, Regina E., Matthew Lingenbrink, Joshua Turnbull, and Ricardo Reisen De Pinho. "OdontoPrev." Harvard Business School Case 314-038, September 2013. (Revised May 2014.)
- Article
Narrow Networks on the Health Insurance Marketplaces: Prevalence, Pricing, and the Cost of Network Breadth
By: Leemore S. Dafny, Igal Hendel, Victoria Marone and Christopher Ody
Anecdotal reports and systematic research highlight the prevalence of narrow-network plans on the Affordable Care Act’s health insurance Marketplaces. At the same time, Marketplace premiums in the period 2014–2016 were much lower than projected by the Congressional... View Details
Dafny, Leemore S., Igal Hendel, Victoria Marone, and Christopher Ody. "Narrow Networks on the Health Insurance Marketplaces: Prevalence, Pricing, and the Cost of Network Breadth." Health Affairs 36, no. 9 (September 2017).
- September 2, 2020
- Article
How to Pay for Public Option Without Tax Hike
By: Regina E. Herzlinger and Richard Boxer
A bipartisan combination of the two parties’ most popular initiatives can expand health care coverage, significantly reduce costs, and enable freedom of choice, without raising taxes. Along the way, we can revitalize competition between public and private plans. Our... View Details
Keywords: Health Insurance; Public Option; Health Care and Treatment; Insurance; Cost Management; United States
Herzlinger, Regina E., and Richard Boxer. "How to Pay for Public Option Without Tax Hike." RealClearPolicy (September 2, 2020).
- March 2015 (Revised January 2024)
- Case
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen (HBS MBA ’01) hoped to win over a prominent venture capital investor for Series B financing of his firm CVI that was creating a drug-eluting balloon (DES) to treat peripheral arterial disease. As a second-mover, Duke felt he was more likely to acquire... View Details
Keywords: CV Ingenuity; CVI; Drug Eluting Balloon; DEB; Drug Eluting Stent; Angioplasty Balloon; FoxHollow; Medical Device; Medical Device Startup; Premarket Approval; PMA; Lutonix; Stellarex; LEVANT; ILLUMENATE; Clinical Trials; Peripheral Arterial Disease; PAD; Healthcare Startups; Covidien; Health Care and Treatment; Health Testing and Trials; Business Startups; Commercialization; Health Industry; Health Industry; United States; Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies." Harvard Business School Case 315-045, March 2015. (Revised January 2024.)
- February 2019
- Article
Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health Care Spending
By: David Cutler, Jonathan Skinner, Ariel Dora Stern and David Wennberg
There is considerable controversy about the causes of regional variations in health care expenditures. Using vignettes from patient and physician surveys linked to fee-for-service Medicare expenditures, this study asks whether patient demand-side factors or physician... View Details
Cutler, David, Jonathan Skinner, Ariel Dora Stern, and David Wennberg. "Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health Care Spending." American Economic Journal: Economic Policy 11, no. 1 (February 2019): 192–221.
- March 2020
- Case
A Tower for the People: 425 Park Avenue
By: John Macomber, Joseph G. Allen and Emily Jones
Healthy buildings and superior air quality are increasingly important since people now spend so much time indoors. Indoor spaces drive performance and productivity. Commercial real estate landlords and investors are responding to the demands of sophisticated tenants... View Details
Keywords: Health And Wellness; Real Estate; Sustainability; Health; Pollution; Buildings and Facilities; Performance Productivity; Finance; Real Estate Industry; New York (city, NY)
Macomber, John, Joseph G. Allen, and Emily Jones. "A Tower for the People: 425 Park Avenue." Harvard Business School Case 220-065, March 2020.
- January 19, 2024
- Article
Value-Based Health Care Can Transform the Treatment of Patients with Substance Use Disorder
By: Robert S. Kaplan and Sarah E. Wakeman
U.S. overdose deaths currently exceed 100,000 per year. New facilities, known as bridge clinics, are broadening access to high-quality care by offering outpatient substance use disorder (SUD) treatment with few access barriers. But many of the critical services offered... View Details
Kaplan, Robert S., and Sarah E. Wakeman. "Value-Based Health Care Can Transform the Treatment of Patients with Substance Use Disorder." Health Affairs Forefront (January 19, 2024).
- June 2024
- Case
Lana Ghanem: Pushing the Boundaries of Health Care through Venture Capital
By: Joshua D. Margolis and Ahmed Dahawy
Lana Ghanem, managing director of Hikma Ventures, the corporate venture arm of larger pharmaceutical group Hikma, is considering how to grow the venture arm as well as progress her own career. Over the past few years Hikma's executive team had been pressuring the... View Details
- March 2021
- Supplement
Humana (C) — Reorganization
By: Regina E. Herzlinger and Ashley Ifeadike
A summary of Humana's restructuring of its business around its pillars. View Details
Keywords: Health Care; Health Care Industry; Health Insurance; Health Care Operations; Health; Health Care and Treatment; Insurance; Operations; Restructuring; Health Industry
Herzlinger, Regina E., and Ashley Ifeadike. "Humana (C) — Reorganization." Harvard Business School Supplement 321-122, March 2021.